PIN1 (Peptidyl-prolyl cis-trans Isomerase NIMA-Interacting 1) is a peptidyl-prolyl cis-trans isomerase that specifically binds to phosphorylated serine/threonine-proline motifs and catalyzes the isomerization of peptide bonds. PIN1 is a critical regulator of protein function in multiple signaling pathways and has been implicated in Alzheimer's disease, Parkinson's disease, and other neurodegenerative conditions.
PIN1 (Peptidyl-prolyl cis-trans Isomerase NIMA-Interacting 1) is a peptidyl-prolyl cis-trans isomerase that specifically binds to phosphorylated serine/threonine-proline motifs and catalyzes the isomerization of peptide bonds. PIN1 is a critical regulator of protein function in multiple signaling pathways and has been implicated in Alzheimer's disease, Parkinson's disease, and other neurodegenerative conditions.
PIN1 is a unique peptidyl-prolyl cis-trans isomerase (PPIase) that catalyzes the isomerization of peptide bonds preceding phosphorylated serine or threonine residues. This post-translational modification can dramatically alter protein conformation and function.
Structural Features
WW Domain: N-terminal domain that recognizes phosphorylated serine/threonine-proline motifs
PPIase Domain: C-terminal catalytic domain that catalyzes cis-trans isomerization
Substrate Specificity: Highly specific for pSer/Thr-Pro motifs, unique among PPIases
Biological Functions
[Tau](/proteins/tau) Phosphorylation Regulation: PIN1 binds to phosphorylated tau (p-tau) and promotes proper tau folding, preventing aggregation
Cell Cycle Regulation: Controls entry and progression through mitosis via regulation of mitotic proteins
Signal Transduction: Modulates signaling pathways including MAPK, PI3K/AKT, and Wnt/β-catenin
Transcriptional Regulation: Influences transcription factor activity including p53, c-Jun, and [NF-κB](/entities/nf-kb)
Protein Quality Control: Aids in proper folding and trafficking of proteins
Disease Associations
Alzheimer's Disease
PIN1 plays a complex role in AD pathophysiology:
Beneficial Function: Catalyzes isomerization of phosphorylated tau, promoting proper tau function
Pathogenic Dysfunction: In AD brain, PIN1 activity is reduced, leading to tau hyperphosphorylation and neurofibrillary tangle formation
Therapeutic Target: PIN1 activators are being explored as potential AD therapeutics
Reference: [Lu et al., Science (1999)](https://doi.org/10.1126/science.286.5446.1741)
Parkinson's Disease
PIN1 levels are altered in PD brains
May regulate [α-synuclein](/proteins/alpha-synuclein) phosphorylation and aggregation
Reference: [Sala et al., J. Neurochem. (2009)](https://pubmed.ncbi.nlm.nih.gov/19250338/)
Cancer
Overexpression in multiple cancers including breast, prostate, and lung
Promotes cell proliferation and survival
Reference: [Lu et al., Nat. Rev. Cancer (2009)](https://doi.org/10.1038/nrc2734)
Expression
Brain Expression
Cerebral [Cortex](/brain-regions/cortex): Moderate to high expression, particularly in pyramidal [neurons](/entities/neurons)
[Hippocampus](/brain-regions/hippocampus): High expression in CA1-CA3 regions and dentate gyrus
Substantia Nigra: Present in dopaminergic neurons
Cerebellum: Moderate expression in Purkinje cells
Cellular Localization
Nuclear: Predominantly nuclear localization
Cytoplasmic: Also present in cytoplasm
Neuronal Processes: Localizes to [dendritic spines](/mechanisms/dendritic-spines)
Common Variants
| Variant | Function | Disease Association | |---------|----------|---------------------| | S16E | Polymorphism | Possible altered activity | | Q33K | Polymorphism | None confirmed | | H89A | Loss of function | Research tool |
Therapeutic Implications
Drug Development
PIN1 Activators: Pharmaceutical compounds that enhance PIN1 activity for AD treatment
PIN1 Inhibitors: Being developed for cancer therapy
Reference: [Pastorino et al., Nat. Rev. Drug Discov. (2016)](https://doi.org/10.1038/nrd.2016.138)
Biomarker Potential
PIN1 expression in CSF may serve as a biomarker for neurodegeneration
Reference: [Matsuda et al., J. Alzheimers Dis. (2015)](https://pubmed.ncbi.nlm.nih.gov/25824923/)